Abstract: A paste for formation of ceramic capacitor electrode, composed of 10 to 14% by weight of an organic vehicle and 86 to 90% by weight of a platinum powder, wherein the platinum powder contains, in 100% by weight of the powder, 54 to 60% by weight of a spherical particle powder, 36 to 40% by weight of a flaky particle powder and 0 to 10% by weight of an indefinite particle powder. The electrode layer film of ceramic capacitor formed with the paste has a density, a surface roughness and an adhesion strength all of given values, can have improved adhesivity to the dielectric layer of the ceramic capacitor, and can make small the through holes generated in the electrode layer.

Abstract: A paste for formation of ceramic capacitor electrode, composed of 10 to 14% by weight of an organic vehicle and 86 to 90% by weight of a platinum powder, wherein the platinum powder contains, in 100% by weight of the powder, 54 to 60% by weight of a spherical particle powder, 36 to 40% by weight of a flaky particle powder and 0 to 10% by weight of an indefinite particle powder. The electrode layer film of ceramic capacitor formed with the paste has a density, a surface roughness and an adhesion strength all of given values, can have improved adhesivity to the dielectric layer of the ceramic capacitor, and can make small the through holes generated in the electrode layer.

Abstract: The first card accommodating portion for accommodating the first card and the second card accommodating portion for accommodating the second card are formed in the connector housing in such a way that a part of the first and second card accommodating portions can be used commonly by the first and second cards. This construction allows two or more kinds of cards with different external shapes and different contact pad positions to be inserted into the connector from one and the same card insertion slot, thus reducing the space occupied by the card connector.

Abstract: The first card accommodating portion for accommodating the first card and the second card accommodating portion for accommodating the second card are formed in the connector housing in such a way that a part of the first and second card accommodating portions can be used commonly by the first and second cards. This construction allows two or more kinds of cards with different external shapes and different contact pad positions to be inserted into the connector from one and the same card insertion slot, thus reducing the space occupied by the card connector.

Abstract: A memory card is to be inserted into an electronic device so as to add a memory function. The memory card comprises a parent card and a child card, the child card including a semiconductor memory element and a lead as an external terminal of the memory element. The parent card includes a child card receiving portion and a child card insert port for inserting the child card into the child card receiving portion through the child card insert port, and a contact to be contacted with the lead of the child card within the child card receiving portion. A contact opening/closing slide plate is provided for causing a contacting portion of the contact to be shifted to a position in which it can contact with the lead while moving in the child card insert direction pushed by the child card. The parent card also includes a connector element for contacting with the electronic device.

Abstract: A memory card is to be inserted into an electronic device so as to add a memory function. The memory card comprises a parent card and a child card, the child card including a semiconductor memory element and a lead as an external terminal of the memory element. The parent card includes a child card receiving portion and a child card insert port for inserting the child card into the child card receiving portion through the child card insert port, and a contact to be contacted with the lead of the child card within the child card receiving portion. A contact opening/closing slide is provided for causing a contacting portion of the contact to be shifted to a position in which it can contact with the lead while moving in the child card insert direction pushed by the child card. The parent card also includes a connector element for contacting with the electronic device.

Abstract: A memory card comprises a flash memory for storing data, in which defective block data indicating defective one of memory blocks constituting the flash memory is stored in advance, and an attribute memory for storing attribute data of the memory card, wherein the defective block data is stored in a blank area of the attribute memory so as to assure that the defective block data is regenerated in the flash memory in a case where the defective block data on the flash memory is erased.

Abstract: A binding agent for a growth factor selected from the group consisting of transforming growth factor-.beta. (TGF-.beta.) and platelet-derived growth factor (PDGF), comprising a protein-bound polysaccharide which is obtained from a fungus belonging to Coriolus, and contains about 18 to 38% by weight of proteins, and a pharmaceutically acceptable carrier or diluent is disclosed.

Abstract: For determining 3-deoxyglucosone derivatives which are intermediate metabolites of the Maillard reaction in body fluids such as blood, urine, serum, plasma and the like in gas chromatography/mass spectrometry, .sup.13 C-labelled compounds or .sup.14 C-labelled compounds are useful as an internal standard substance. More specifically, 3-deoxyglucosone derivatives having the formula (I): ##STR1## wherein *C is .sup.13 C or .sup.14 C, X is O or N--OR wherein R is Me, Et or H, and Y is SiMe.sub.3 or SiMe.sub.2 tBu, and their production are provided. The measurement of 3-deoxyglucosone derivatives is useful in diagnosing diseases such as diabetes and diseases complicated with diabetes, including diabetic nephrosis, various renal disorders, renal insufficiency, metabolic diseases of carbohydrate and the like.

Abstract: For determining 3-deoxyglucosone derivatives which are intermediate metabolites of the Maillard reaction in body fluids such as blood, urine, serum, plasma and the like in gas chromatography/mass spectrometry, .sup.13 C-labelled compounds or .sup.14 C-labelled compounds are useful as an internal standard substance. More specifically, 3-deoxyglucosone derivatives having the formula (I): ##STR1## wherein *C is .sup.13 C or .sup.14 C, X is O or N--OR wherein R is Me, Et or H, and Y is SiMe.sub.3 or SiMe.sub.2 tBu, and their production are provided. The measurement of 3-deoxyglucosone derivatives is useful in diagnosing diseases such as diabetes and diseases complicated with diabetes, including diabetic nephrosis, various renal disorders, renal insufficiency, metabolic diseases of carbohydrate and the like.

Abstract: For determining 3-deoxyglucosone derivatives which are intermediate metabolites of the Maillard reaction in body fluids such as blood, urine, serum, plasma and the like in gas chromatography/mass spectrometry, .sup.13 C-labelled compounds or .sup.14 C-labelled compounds are useful as an internal standard substance. More specifically, 3-deoxyglucosone derivatives having the formula (I): ##STR1## wherein *C is .sup.13 C or .sup.14 C, X is O or N--OR wherein R is Me, Et or H, and Y is SiMe.sub.3 or SiMe.sub.2 tBu, and their production are provided. The measurement of 3-deoxyglucosone derivatives is useful in diagnosing diseases such as diabetes and diseases complicated with diabetes, including diabetic nephrosis, various renal disorders, renal insufficiency, metabolic diseases of carbohydrate and the like.

Abstract: A ceramic green sheet comprises a green sheet as a core and a surface layer formed thereon. Such ceramic green sheets are laminated for use in IC package, printed circuit board or the like.

Abstract: Disclosed is a pharmaceutical composition containing p-aminobenzoic acid-N-D-xyloside or a pharmaceutically a acceptable salt thereof as an active ingredient.

Abstract: Disclosed is a pharmaceutical composition containing p-aminobenzoic acid-N-D-xyloside or a pharmaceutically a acceptable salt thereof as an active ingredient.

Abstract: Disclosed herein is a nucleic acid-containing glycoprotein having molecular weight of 5,000 to 300,000 as determined by ultracentrifugal method; the weight ratio of protein moiety thereof determined by Lowry-Folin's method to saccharide moiety thereof determined by phenol-sulfuric acid method of in the range of 50/50 to 80/20; N-terminal amino acid thereof consisting essentially of tyrosine, leucine or alanine; leucine-phenylalanine-valine as amino acid sequence at C-terminal thereof; the elementary composition consisting essentially of 35.2 to 49.3% of C, 4.8 to 8.0% of H, 4.3 to 12.3% of N, trace to 2.5% of S, trace to 1.2% of P and the balance of O; the isoelectric point of in the range of pH 2.5 to 5.0; and nucleic acid as a component.